Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers

Title
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers
Authors
Keywords
Neisseria meningitidis, Serogroup B, Vaccine, Meningococcal disease, Bivalent rLP2086, Laboratory worker
Journal
VACCINE
Volume 34, Issue 6, Pages 809-813
Publisher
Elsevier BV
Online
2015-12-19
DOI
10.1016/j.vaccine.2015.12.016

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started